Correlation Between Edgewise Therapeutics and MaxCyte
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and MaxCyte, you can compare the effects of market volatilities on Edgewise Therapeutics and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and MaxCyte.
Diversification Opportunities for Edgewise Therapeutics and MaxCyte
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and MaxCyte is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and MaxCyte go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and MaxCyte
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the MaxCyte. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.64 times less risky than MaxCyte. The stock trades about -0.12 of its potential returns per unit of risk. The MaxCyte is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 357.00 in MaxCyte on August 30, 2024 and sell it today you would lose (5.00) from holding MaxCyte or give up 1.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. MaxCyte
Performance |
| Timeline |
| Edgewise Therapeutics |
| MaxCyte |
Edgewise Therapeutics and MaxCyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and MaxCyte
The main advantage of trading using opposite Edgewise Therapeutics and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.| Edgewise Therapeutics vs. Ikena Oncology | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. Tempest Therapeutics |
| MaxCyte vs. ReShape Lifesciences | MaxCyte vs. Bone Biologics Corp | MaxCyte vs. Tivic Health Systems | MaxCyte vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |